Average Co-Inventor Count = 6.98
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (26 from 2,405 patents)
2. Merck + Co., Inc. (1 from 4,770 patents)
27 patents:
1. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists
2. 10766919 - Cyclic di-nucleotide compounds as sting agonists
3. 10759825 - Cyclic di-nucleotide compounds as STING agonists
4. 10604534 - C5-C6-oxacyclic fused iminothiadiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
5. 10414774 - Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
6. 10414775 - Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
7. 10351558 - Factor IXa inhibitors
8. 10329291 - C5-C6-carbocyclic fused iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
9. 10106574 - Cyclic di-nucleotide compounds as sting agonists
10. 10071998 - Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use
11. 10000484 - Inhibitors of the renal outer medullary potassim channel
12. 9777002 - Inhibitors of the renal outer medullary potassium channel
13. 9732088 - C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
14. 9604998 - Inhibitors of the renal outer medullary potassium channel
15. 9573961 - Inhibitors of the renal outer medullary potassium channel